AstraZeneca completes Gracell Biotechnologies acquisition for $1.2bn

AstraZeneca has announced the conclusion of its acquisition of Gracell Biotechnologies for approximately $1.2bn.

Feb 24, 2024 - 18:00

AstraZeneca completes Gracell Biotechnologies acquisition for $1.2bn

AstraZeneca has announced the conclusion of its acquisition of Gracell Biotechnologies for approximately $1.2bn.

Read the original article

Tags:

Previous Article

NICE recommends Pfizer’s Ritlecitinib for alopecia areata treatment

AbbVie and Tentarix enter biologic development deal

What's Your Reaction?

0

Like

0

Dislike

0

Love

0

Funny

0

Angry

0

Sad

0

Wow

Related Posts

Senate committee launches bipartisan investigation into private equity ownership of hospitals

Senate committee launches bipartisan investigation into...

Dec 7, 2023

Krystal Biotech receives FDA approval for DEB topical gene therapy

Krystal Biotech receives FDA approval for DEB topical g...

May 26, 2023

PRO-1107 by ProfoundBio Suzhou for Transitional Cell Ca...

Apr 21, 2024